China's Harbin Pharma to buy stake in US health retailer GNC
PITTSBURGH, Feb. 13, 2018 /PRNewswire/ -- GNC Holdings, Inc. (NYSE: GNC) (the "Company") today announced it has reached an agreement regarding a strategic partnership and China joint venture agreement with Harbin Pharmaceutical Group Holding Co., Ltd ("Hayao"), a leading pharmaceutical company in China. Under the terms of the agreement Hayao will invest approximately $300 million in GNC, becoming the single largest shareholder in GNC (on an as converted basis). In addition, GNC and Hayao have agreed to form a joint venture for the manufacturing, marketing, sale and distribution of GNC-branded products in China, leveraging the synergies between Hayao and GNC in the fast growing Chinese market. CITIC Capital Holdings Limited ("CITIC Capital"), as a major shareholder of Hayao, is supportive of the transaction. source:passioncard GNC also announced plans to amend certain terms and extend the maturity date of its existing term loan facility d...